🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Bexmarilimab plus azacitidine for high-risk myelodysplastic syndrome and relapsed or refractory acute myeloid leukaemia: results from the dose-escalation part of a multicentre, single-arm, phase 1/2 trial - The Lancet Haematology thelancet.com/journals/lanha…

Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study - The Lancet Haematology thelancet.com/journals/lanha…

Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial - The Lancet Haematology thelancet.com/journals/lanha…

Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial - The Lancet Oncology thelancet.com/journals/lanon…

Matched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion ashpublications.org/blood/article/…

Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndrome ashpublications.org/blood/article/…

A single dose of a CD137 antibody-drug conjugate protects nonhuman primate allogeneic HCT recipients against acute GVHD ashpublications.org/blood/article-…

Age-Adjusted Dosing of Fludarabine for Lymphodepletion in CAR T-cell Therapy: A Clinical Trial Simulation Study ashpublications.org/bloodadvances/…

­­­RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease Following Allogeneic HCT ashpublications.org/blood/article-…

Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab ashpublications.org/blood/article-…

Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab-- ashpublications.org/blood/article-…

Current developments in T-cell receptor therapy for acute myeloid leukemia ashpublications.org/bloodadvances/…

In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis ashpublications.org/bloodadvances/…

I can't understand e.g. if the stem cell lab refused to release the specifications of cellular therapy product e.g. CD34, TNC,etc... Where is the quality? #Novartis more practical in the this issue

Sustained Remission of Refractory EBV-Associated CNS Post-Transplant Lymphoproliferative Disorder After Cord Blood Transplantation Using Donor-Derived CD19/CD20 Bispecific CAR-T Cells in a Pediatric Patient With GATA2 Deficiency onlinelibrary.wiley.com/doi/abs/10.100…